Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|November 3, 2010

Diagnostic Imaging

  • Diagnostic Imaging Vol 32 No 10
  • Volume 32
  • Issue 10

MRI reveals when cognitive impairment will advance

Swiss researchers used susceptibility-weighted MRI and an artificial intelligence technique to help identify which individuals with mild cognitive impairment will continue to decline.

Swiss researchers used susceptibility-weighted MRI and an artificial intelligence technique to help identify which individuals with mild cognitive impairment will continue to decline.

Susceptibility-weighted MRI measures magnetic susceptibility phase-effect differences between tissues. Using the technique, researchers were able to view details of the blood vessels in the brain, including microhemorrhages and microbleeds.

The scans revealed microbleeds in 33% subjects with stable mild cognitive impairment. They found microbleeds in 54% of those with progressive cognitive impairment and in 14% of the control group. The study appeared in Radiology.

The researchers also analyzed the data with support vector technology algorithms to identify patterns within a group and create classifications. By adding the support vector technology to the baseline MRI data the researchers were able to distinguish patients with mild cognitive impairment with 85% accuracy.

Articles in this issue


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.